Despite Several Factors Supporting Osteoporosis Drugs Market, Patent Expiration of Blockbuster Drugs to Hamper Market's Progress: TMR

- With growing age, the hormones such as estrogen and androgen in females and males respectively, goes drastically down. This as a result reduces the density of bones and cause osteoporosis. This is the major factor that propels the growth of global osteoporosis drugs market.

- Development of generic drugs that can replenish the body with minerals like calcium and phosphate is expected to impact the revenue of the global osteoporosis drugs market during the tenure.

News provided by

Transparency Market Research

Mar 10, 2020, 06:30 ET

ALBANY, New York, March 10, 2020 /PRNewswire/ -- With the rapid increase in geriatric population across the globe, the demand for drugs or supplements that can provide minerals such as calcium and phosphate to the consumers has increased significantly. These developments are in the pursuit to develop effective treatment for the patients suffering from osteoporosis disease. Owing to these developments the global osteoporosis drugs market is expected to witness a substantial growth from 2019 to 2027, says a recent report by Transparency Market Research.

"The growth in the geriatric population has stimulated the people to pay extra attention to their health. It is quite common for the people above the age of 60 to have deficiency of minerals like phosphate and calcium along with lowered levels of hormones such as estrogen in females and androgens in males. These minerals and hormones help the body to maintain the density of the bones. Therefore their deficiency can lead to some serious problems. In order to overcome these issues, pharmaceutical companies are investing in research and developments to develop effective drugs that can help the patients to overcome this condition. However, though there are various drivers that aiding the global osteoporosis drugs market to maintain a robust growth, the market is still projected to show ~-0.3% CAGR and shall drop down to US$ 11.3 Bn by the end of 2027 from US$ 11.5 Bn in 2018." –Transparency Market Research.

Read Detailed TOC of the Report - https://www.transparencymarketresearch.com/report-toc/133

Key Insights from Global Osteoporosis Drugs Market Study

To provide a 360 degree analysis of the global osteoporosis drugs market, the report by Transparency Market Research categorizes the market into various categories. These categories are further divided into various segments. With the help of these insights the businesses can understand the dynamics of the global osteoporosis drugs market and can derive strategies that can help the players to have a sustainable future in the global osteoporosis drugs market during the tenure of 2019 to 2027. Some of the key insights from global osteoporosis drugs market study are mentioned below:

Bisphosphonates segment under drug class category is expected to dominate the global osteoporosis drugs market. This dominance of the segment is the result of extensive prescription of the compound and better results that its counterparts available in the global osteoporosis drugs market.
Sclerostin inhibitor segment is projected to emerge as the fastest growing segment in the global osteoporosis drugs market. The momentum of the segment is driven by the adoption of novel drugs approach for the treatment of osteoporosis. Moreover, arrival of new products containing Sclerostin inhibitors in 2019 is also a major factor that shall propel the segment to have a steady growth in the global osteoporosis drugs market from 2019 to 2027.

Explore the actionable insights from the report on global osteoporosis drugs market available under the title: Osteoporosis Drugs Market (By Drug Class Bisphosphonates, Calcitonin, RANK Ligand Inhibitors, Parathyroid Hormone Therapy (PTH), Selective Estrogen Receptor Modulators (SERMs), Others Estrogen therapy and vitamin D and Calcium) - Global Industry Analysis, Pipeline Analysis, Size, Share, Growth, Trends & Forecast 2019 – 2027 at

Download a PDF Brochure of the Report – https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=133

Key Divers Mentioned in the Global Osteoporosis Drugs Market Study

With the information about the drivers mentioned in the report by Transparency Market Research, the readers can understand the momentum of the global osteoporosis drugs market. The insights from the report can also help the players to leverage maximum of the potential offered by the progressing market. This in turn shall help the players of global osteoporosis drugs market to have better growth opportunities and a brighter future in the global osteoporosis drugs market from 2019 to 2027. Some of the major drivers mentioned in the report are:

Increase in the prevalence of osteoporosis in elderly people across the globe is considered as the major factor that propels the growth of global osteoporosis drugs market from 2019 to 2027. To overcome this bone condition, the pharmaceutical companies are developing effective generic drugs that can help the patient to maintain the density of bones. Owing to this development, the global osteoporosis drugs market is projected to grow substantially in the coming years of 2019 to 2027.
Increasing geriatric population across the globe coupled with growing deficiency of vital minerals in women is also a prominent factor that is propelling the demand for osteoporosis drugs resulting in accelerated growth of global osteoporosis drugs market from 2019 to 2027.

Key Challenges Mentioned in the Global Osteoporosis Drugs Market Study

The report by Transparency Market Research not only provides insights on the positive aspects, but also help the readers to understand the challenges and roadblocks that might hamper the growth of global osteoporosis drugs market. With the help of these insights the players can derive effective strategies that can help them overcome these situations and have a sustainable future in the global osteoporosis drugs market from 2019 to 2027. Some of the major challenges mentioned in the report are as follow:

Patent expiration is the major factor that shall significantly hamper the growth of the global osteoporosis drugs market. This is because, of the acceptance of generic equivalents of branded drugs that costs the consumers 1/10^th of the osteoporosis drugs. During the first year of forecast period, this factor decreased the revenue generation of 35% to 40%.

Global Osteoporosis Drugs Market: Regional Analysis

North America dominated the regional front of global osteoporosis drugs market during the tenure of 2019 to 2027. This dominance of the market is the result of staggering number of osteoporosis in the U.S. and Canada. Moreover, improving healthcare infrastructure in the U.S. is also a major factor that propels the growth of North America in global osteoporosis drugs market from 2019 to 2027.

Nevertheless, Asia Pacific is projected to emerge as the fastest growing region in the global osteoporosis drugs market. This pacing growth is the result of growing disposable income of the people in the countries like India and China. This allows the patients to opt for state of the art treatments conveniently. Owing to these factors Asia Pacific to exhibit high potential for the players of global osteoporosis drugs market from 2019 to 2027.

Analyze osteoporosis drugs market growth in 30+ countries including US, Canada, Germany, United Kingdom, France, Italy, Russia, Poland, Benelux, Nordic, China, Japan, India, and South Korea. Request a sample of the study\.

Competitive Landscape:

The global osteoporosis drugs market is highly competitive and largely consolidated. This is because, the market is dominated by handful of prominent players. The presence of these players is making it difficult for new players to enter the global osteoporosis drugs market.

To overcome this situation, the players are involving in strategies such as mergers and collaborations. With the help of these resource, the new players can avail a sustainable future in the global osteoporosis drugs market.

The global Osteoporosis Drugs market has been segmented as follows:

Global Osteoporosis Drugs Market, by Drug Class

Bisphosphonates
Calcitonin
RANK Ligand Inhibitor
Parathyroid Hormone Therapy (PTH)
Selective Estrogen Receptor Modulators (SERMs)
Sclerostin Inhibitor
Others

Global Osteoporosis Drugs Market, by Region

North America

U.S.
Canada

Latin America

Mexico
Brazil
Argentina
Chile
Peru
Rest of Latin America

Europe

Germany
Italy
France
U.K.
Spain
Benelux
Nordic
Russia
Poland
Rest of Europe

Asia Pacific (APAC)

China
India
ASEAN
Australia & New Zealand
Japan
Rest of APAC

Middle East & Africa (MEA)

GCC Countries
Turkey
North Africa
South Africa
Israel
Nigeria
Rest of Middle East & Africa

Explore Transparency Market Research's award-winning coverage of the global Healthcare industry:

Parathyroid Hormone Market - Increase in incidence and prevalence of conditions related to the imbalance in the parathyroid hormone level in the body due to changing lifestyles, surge in R&D on the development of parathyroid hormone analogues, and improved diagnostic procedures for the detection of parathyroid hormone imbalance are projected to drive the global parathyroid hormone market during the forecast period.

Estrogen Replacement Therapy (ERT) Market - Due to change in hormonal levels in the body, women suffer from various debilitating symptoms. ERT is one of the hormone replacement therapies that includes replenishment of estrogen hormone levels in women through administration of external estrogen and/or progesterone hormones. Estrogen replacement therapy helps in treating women suffering from menopausal symptoms. It decreases the symptoms like vaginal dryness, hot flashes, disturbed sleep, night sweats, etc. ERT helps in osteoporosis prevention caused due to depletion of estrogen levels in the body.

Vitamin D Testing Market - Stakeholders in the vitamin D testing landscape are evaluating the use of HPLC (High Performance Liquid Chromatography) to assess the analytical performance of the 25-hydroxy D vitamin test in human serum. This has been validated with the help of the electrochemiluminescence (ECL) method.

Gain access to Market Ngage, an AI-powered, real-time business intelligence that goes beyond the archaic research solutions to solve the complex strategy challenges that organizations face today. With over 15,000+ global and country-wise reports across 50,000+ application areas, Market Ngage is your tool for research on-the-go. From tracking new investment avenues to keeping a track of your competitor's moves, Market Ngage provides you with all the essential information to up your strategic game. Power your business with Market Ngage's actionable insights and remove the guesswork in making colossal decisions.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision."

Contact

Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: [email protected]
Website: http://www.transparencymarketresearch.com

SOURCE Transparency Market Research